22157.jpg
NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)
26 avr. 2024 04h12 HE | Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "NK Cell Therapies - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
Tumor Infiltrating Lymphocytes Industry Projected to Reach $18.32 Billion by 2028 - Emerging Technologies, such as cytoDRIVE, and Strategic Alliances Propelling the Global Market Forward
23 janv. 2024 09h43 HE | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Growth Driven by...
Global Natural Killer Cells Therapeutics Market
Global Natural Killer Cells Therapeutics Research Report 2023: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2022 and 2023-2028
03 janv. 2024 11h33 HE | Research and Markets
Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
22157.jpg
Immunotherapy Targeting Mesothelin: A Comprehensive 2023 Pipeline Review
14 déc. 2023 05h43 HE | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. A groundbreaking review of...
22157.jpg
Natural Killer Cells Therapeutics Market Analysis and Industry Forecast to 2027: Advancements in Manufacturing Processes, Cell Engineering Techniques and Development of Combination Therapies
07 août 2023 06h03 HE | Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027" report...
Global Urothelial Cancer Drugs Market
Global Web Analytics Market to Reach $13.92 Billion by 2027, Driven by Growing Demand for Online Shopping and Technological Advancements
14 juil. 2023 04h53 HE | Research and Markets
Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global web analytics market is...
Global Tumor Infiltrating Lymphocytes Market
Tumor Infiltrating Lymphocytes Global Market Report 2023: Sector to Reach $15.56 Billion by 2027 at a 13.7% CAGR
23 mai 2023 04h53 HE | Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tumor infiltrating...
22157.jpg
Global Checkpoint Inhibitors Competitive Landscape Report 2023: Comprehensive Insights About 180+ Companies and 250+ Drug Profiles
08 mai 2023 06h48 HE | Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Checkpoint inhibitors -...
22157.jpg
Market Forecasts for Immuno-Oncology Diagnostics 2023: Outcome Potential and Companion Diagnostics Driving Growth
16 janv. 2023 07h58 HE | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2023 to 2027" report has...
NKGen Biotech RGB small.jpg
NKGen Biotech Appoints Paul Y. Song, MD as Chief Executive Officer
10 janv. 2023 13h27 HE | NKGen Biotech
SANTA ANA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of natural killer cell therapies,...